health care for
gMENDEL WAS INSPIRED BY THE PERSONAL STORIES OF THE TWO FOUNDERS, CHRIS AND ZORAN.
In 2016, Chris’s 4-year-old daughter, Ilma, was diagnosed with selective mutism. The diagnosis forced Chris and his family to slow down and reflect on what was important in life. It was then when Chris decided to take a 10-month parental leave to give his daughter the time and attention she needed to thrive. With the strong support of her family, Ilma made tremendous progress and is now taking part in all learning and social activities at her school.
Some years ago, Zoran received the news that his childhood friend suffered from a rare cancer type. The exact diagnosis was only possible after DNA sequencing. While going through the complicated journey of healthcare, Zoran realized that although DNA sequencing had been a long-available technology, it was only accessible to few, due to its high cost.
Their ambition to involve DNA sequencing in routine clinical practice, led Chris and Zoran to the foundation of gMendel® in 2020.
They committed to developing a smart technology that could provide early, accurate and affordable diagnosis of genetic disorders to all heroes out there living with rare diseases.
At gMendel® we think big, start small and act now.
27 Sep 2021MIT researchers employ machine learning to find powerful peptides that could improve a gene therapy drug for Duchenne muscular dystrophy (DMD).
20 Sep 2021gMendel is giving an interactive presentation about transforming the diagnosis of genetic disorders at the SKEL | The AI Lab, Athens
23 Jul 2021Scientists report first clinical data showing that CRISPR gene editing can be done safely inside the body.
23 Jul 2021How CRISPR gene editing will treat diseases in future: Interview by Nobel-winner Intellia Jennifer Doudna.
A genetic disorder is a disease caused in whole or in part by a change in the DNA sequence away from the normal sequence.
Genetic disorders can be caused by a mutation in one gene, by mutations in multiple genes, by a combination of gene mutations and environmental factors, or by damage to chromosomes, the structures that carry genes.
gMendel contributes to the communities where we live. We are committed to our employees, diversity, equity, inclusion, and environmental sustainability.
We partner with Besesaka Foundation. Besesaka is changing the realities of children in Ghana through boxing, education and leadership development. Besesaka’s long-term aim is to establish a Boxucation academy, where boxing is as important as education, in Bukom, Ghana by the end of 2023. Until that time, Besesaka provides educational scholarships to boys and girls, who love boxing and are great at it, have excellent academic level and demonstrate a great character.
Through Besesaka and Boxucation, we contribute to developing better leaders and our world will become a better place, one step at a time.